Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in December 2019 quickly escalated to pandemic levels and had a severe impact on public health. There are 761 million confirmed coronavirus disease 2019 (COVID-19) cases, with over 6.88 million deaths worldwide ti...
Saved in:
| Main Authors: | Atri Das, Swarnali Khan, Syamal Roy, Shantanabha Das |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration
2023-10-01
|
| Series: | Exploration of Drug Science |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A100824/100824.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytokine, chemokine, and acute-phase protein profiles in plasma as correlative biomarkers of clinical outcomes for patients with COVID-19
by: Sierra G. Vanderkamp, et al.
Published: (2025-05-01) -
Severe Acute Respiratory Syndrome Coronavirus-2 and Tuberculosis Coinfection: Double Trouble
by: Abhijeet Singh, et al.
Published: (2020-07-01) -
The Race to Find COVID-19 Vaccine: So Near, Yet so Far!
by: Sonali Sachdeva, et al.
Published: (2020-10-01) -
The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
by: Tao Liu, et al.
Published: (2020-06-01) -
Association of Clinicodemographic Factors and Vaccination Status with COVID-19 Positivity in a Tertiary Care Hospital in Southern India: A Cross-sectional Study
by: Soumya Kaup, et al.
Published: (2025-03-01)